Navigation Links
Cooling may benefit children after cardiac arrest
Date:12/3/2009

NEW YORK (December 3, 2009) -- When the heart is stopped and restarted, the patient's life may be saved but their brain is often permanently damaged. Therapeutic hypothermia, a treatment in which the patient's body temperature is lowered and maintained several degrees below normal for a period of time, has been shown to mitigate these harmful effects and improve survival in adults.

Now, in the first large-scale multicenter study of its kind, physician-scientists are evaluating the effectiveness of the technique in infants and children. Offered exclusively in New York by Columbia University Medical Center researchers at NewYork-Presbyterian Morgan Stanley Children's Hospital, the Therapeutic Hypothermia After Pediatric Cardiac Arrest (THAPCA) trial is funded by the National Heart, Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH).

"A tragedy no matter how it happens, cardiac arrest can occur in children either as a complication from a serious medical condition or due to an accident or sudden illness. While arrest in children is rare, currently no therapies have been shown to improve their chances of recovering," says Dr. Charles Schleien, a pediatrician and anesthesiologist at NewYork-Presbyterian Morgan Stanley Children's Hospital and executive vice chairman of pediatrics and professor of pediatrics and anesthesiology at Columbia University College of Physicians and Surgeons. "In this new study, we aim to show that therapeutic hypothermia can give these children a better chance at survival and long-term quality of life."

Study participants will be randomly selected to either have their body cooled through therapeutic hypothermia or maintained at normal body temperature. In both groups, body heat will be adjusted using special temperature-control blankets. Those receiving hypothermia will have their body temperature reduced to between 89.6 and 93.2 Fahrenheit (F) for two days, then slowly increased to a normal body temperature and maintained for another three days.

Co-led by Dr. Frank W. Moler at the University of Michigan C.S. Mott Children's Hospital and Dr. Michael Dean at the University of Utah, the six-year study involves a total of 16 study sites in North America.

Cardiac Arrest and Therapeutic Hypothermia

During cardiac arrest, the body's blood supply is interrupted and cells are deprived of oxygen. This stresses the body, causing the release of toxic compounds that can overwhelm the organs and result in long-term brain injury. Therapeutic hypothermia slows the body's production of these compounds, reducing risk for brain injury. The therapy has been used successfully in adult cardiac arrest patients, and has been shown beneficial for newborns who have received insufficient oxygen at birth.

A Leader in Cooling for Cardiac Arrest Patients

Beginning this year, New York City ambulances are taking cardiac arrest patients directly to hospitals that offer therapeutic hypothermia. Dr. Stephan Mayer of NewYork-Presbyterian Hospital/Columbia University Medical Center played a key role in establishing this policy by bringing the idea to a critical-care committee of the Greater New York Hospital Association and United Hospital Fund.


'/>"/>

Contact: Belinda Mager
bem9048@nyp.org
212-305-5587
New York- Presbyterian Hospital/Columbia University Medical Center
Source:Eurekalert

Related medicine news :

1. Novel Cooling Therapy May Have Aided Injured Football Player
2. Skin Cooling After Laser Treatment Could Leave Marks
3. Consortium Health Plans Cuts Down on Power Usage and Cooling in Its Data Center Using ONStors Green Clustered NAS Solution
4. Cardium Announces InnerCools Endovascular Cooling to be Featured on Science Channels Series Cool Stuff: How It Works
5. Cooling May Not Help Injured Brains in Children
6. Late-breaking results of clinical trial on therapeutic endovascular cooling reported at TCT 2008
7. Cardium Reports on New York Citys Adoption of Therapeutic Cooling Protocols for Cardiac Arrest Patients
8. BeneChill Launches European Study of Intra-Arrest Cooling
9. Top Neurology Programs Control Fever with Arctic Sun Cooling Technology
10. St. Josephs Healthcare System Becomes First Hospital in the Region to Implement Pre-Hospital Therapeutic Cooling to Save the Lives of Cardiac Arrest Patients
11. Chill Cooling Towels Introduces Instant Relief for Hot Flashes and Night Sweats
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2017)... ... 2017 , ... "On Tour is a music themed slideshow production package which ... Austin - CEO of Pixel Film Studios. , On Tour’s new slide presets ... animation of their slideshows. Place each slide on top of another slide or piece ...
(Date:1/14/2017)... MN (PRWEB) , ... January 14, 2017 , ... ... present the distinctions among their expanding line of activated charcoal products. With more ... the importance of categorizing their products according to how they cater to specific ...
(Date:1/13/2017)... ... ... The 18th European Congress: Perspectives in Lung Cancer will be held in ... is expertly designed to meet the educational needs of European oncology clinicians and researchers ... Dr. Giorgio V. Scagliotti, Professor of Oncology at the University of Torino, and organized ...
(Date:1/13/2017)... ... January 13, 2017 , ... An inventor from Virginia Beach, Va., is always ... order to diversify my outfits, so he decided to design something that enhances the ... the appearance of a belt to allow for quick, easy changing of its look. ...
(Date:1/13/2017)... , ... January 13, 2017 , ... MyGenetx, a molecular ... Communications, and Sales Administration Specialist, Mary Taylor Smith, RD, LD, will serve on the ... serving one year as a board member and one year as Vice President. She ...
Breaking Medicine News(10 mins):
(Date:1/14/2017)... 14, 2017  Johnson & Weaver, LLP announces that a ... Zimmer Biomet Holdings, Inc. (NYSE: ZBH )  securities ... 2016 (the "Class Period"). Zimmer Biomet provides musculoskeletal ... reconstructive products, such as knee and hip reconstructive products. ... According to ...
(Date:1/13/2017)... New York , January 13, 2017 ... rising prevalence of AIDS will collectively contribute to the demand ... expected to reach a value of US$ 551.0 Mn by ... will remain the most lucrative markets for western blotting, ... lead the market globally. ...
(Date:1/13/2017)... , January 13, 2017 This ... see how they have fared at yesterday,s closing bell: ... Biopharma Inc. (NASDAQ: GALE ), and ACADIA ... harness cellular and biomolecular processes to develop technologies and ... environmental footprint, feed the hungry, use less and cleaner ...
Breaking Medicine Technology: